Pathogenesis of hypertension in a mouse model for human CLCN2 related hyperaldosteronism

Corinna Göppner, Ian J. Orozco, Maja B. Hoegg-Beiler, Audrey H. Soria, Christian A. Hübner, Fabio L. Fernandes-Rosa, Sheerazed Boulkroun, Maria-Christina Zennaro and Thomas J. Jentsch ()
Additional contact information
Corinna Göppner: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
Ian J. Orozco: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
Maja B. Hoegg-Beiler: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
Audrey H. Soria: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
Christian A. Hübner: Universitätsklinikum Jena
Fabio L. Fernandes-Rosa: Paris Cardiovascular Research Center
Sheerazed Boulkroun: Paris Cardiovascular Research Center
Maria-Christina Zennaro: Paris Cardiovascular Research Center
Thomas J. Jentsch: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)

Nature Communications, 2019, vol. 10, issue 1, 1-13

Abstract: Abstract Human primary aldosteronism (PA) can be caused by mutations in several ion channel genes but mouse models replicating this condition are lacking. We now show that almost all known PA-associated CLCN2 mutations markedly increase ClC-2 chloride currents and generate knock-in mice expressing a constitutively open ClC-2 Cl− channel as mouse model for PA. The Clcn2op allele strongly increases the chloride conductance of zona glomerulosa cells, provoking a strong depolarization and increasing cytoplasmic Ca2+ concentration. Clcn2op mice display typical features of human PA, including high serum aldosterone in the presence of low renin activity, marked hypertension and hypokalemia. These symptoms are more pronounced in homozygous Clcn2op/op than in heterozygous Clcn2+/op mice. This difference is attributed to the unexpected finding that only ~50 % of Clcn2+/op zona glomerulosa cells are depolarized. By reproducing essential features of human PA, Clcn2op mice are a valuable model to study the pathological mechanisms underlying this disease.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-019-12113-9 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12113-9

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-019-12113-9

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().